Market Overview

Sterne Agee Sees Entry Point In Endo International PLC Shares


Sterne Agee issued a report on Endo International PLC (NASDAQ: ENDP) Tuesday and suggested that "recent weakness" created a "good entry point." The firm maintained a Buy rating and $75 price target.

Analysts Shibani Malhotra and Austin Nelson noted that "Endo has agreed to acquire Auxilium Pharmaceuticals for $33.25 per share ($2.6 billion) in a cash and equity deal. Endo expects to generate synergies of $175million making the deal immediately accretive."

Malhotra commented that Endo "shares have been weak, mostly on unwarranted confusion around management’s guidance regarding Auxilum’s standalone top-line growth and the impact of the deal structure on potential accretion."

The report concluded that "Endo remains one of our top spec pharma picks and we recommend building positions at these levels."

Malhota also mentioned that Endo management indicated "that longer term the company can achieve additional tax synergies as Auxilium is a full US tax payer, which could provide upside to our out year accretion estimates. We estimate that each $10 million in incremental synergies adds $0.04 (0.9-0.94 percent) to 2016 EPS assuming 50-75 percent of equity issuance, respectively."

Endo International PLC recently traded at $61.05, down 0.25 percent.

Latest Ratings for ENDP

Jan 2020PiperJaffrayUpgradesNeutralOverweight
Jul 2019Morgan StanleyDowngradesEqual-WeightUnderweight
Jul 2019RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: Austin Nelson Shibani Malhotra Sterne AgeeAnalyst Color Analyst Ratings


Related Articles (ENDP)

View Comments and Join the Discussion!

Latest Ratings

ANGIAegis CapitalMaintains12.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at